PPH vs SPYM5YPPHPPHAvsBSPYMSPYMVanEck Pharmaceutical ETF · $1.1BState Street SPDR Portfolio S&P 500 ETF · $186BReturns · dividends in+18.8%3 years · per year$16,788 · $17,930+21.5%+12.1%5 years · per year$17,737 · $17,277+11.6%Cost and income0.36%Expense ratio$36 · $2 on $10k · lower wins0.02%1.74%
Overlap: PPH, SPYM, IVVToday99.9%most shared, SPYM and IVVPPHSPYMIVVPPH—5.0%5.0%SPYM5.0%—99.9%IVV5.0%99.9%—End-of-day Nov 13, 2026 · share held in common · outlined: the pair in versus
PPH vs SPYM5YAPPHVanEck Pharmaceutical$17,737vsSPYMBSPDR Portfolio S&P 500$17,277$10k$15kNov 2021Nov 2026
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1APPHVanEck Pharmaceutical ETFReadDesk0.36%1.74%+1.1%+20.9%+26.0%+18.8%+12.1%−10.8%$1.1B2BSPYMState Street SPDR Portfolio S&P 500 ETFReadDesk0.02%1.03%−0.4%+11.5%+11.6%+21.5%+11.6%−8.9%$185.8B3IVViShares Core S&P 500 ETFReadDesk0.03%1.11%−0.4%+11.5%+11.6%+21.5%+11.5%−8.9%$875.2BEnd-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
All Three5Y3 fundsBest 5YLowest feeHighest incomeSmallest dropMost assets#Ticker▲▼Fund▲▼TrendFee▲▼Yield▲▼Today▲▼YTD▲▼1Y▲▼3Y/yr▲▼5Y/yr▼Drop▲▼Assets▲▼1APPHVanEck Pharmaceutical ETFReadDesk0.36%1.74%+1.1%+20.9%+26.0%+18.8%+12.1%−10.8%$1.1B2BSPYMState Street SPDR Portfolio S&P 500 ETFReadDesk0.02%1.03%−0.4%+11.5%+11.6%+21.5%+11.6%−8.9%$185.8B3IVViShares Core S&P 500 ETFReadDesk0.03%1.11%−0.4%+11.5%+11.6%+21.5%+11.5%−8.9%$875.2BEnd-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
SPYM vs SPYYTDSPDRSPYMSA+11.5%vsBSSPYSPDR+11.5%Jan 1Nov 13+11.5%+11.5%+11.5%Year to date+11.5%1.0%Yield1.0%$186BAssets$807B0–0levelEnd-of-day Nov 13, 2026
VOO vs IVVYTDVanguardVOOVA+11.5%vsBiSIVViShares+11.5%Jan 1Nov 13+11.5%+11.5%+11.5%Year to date+11.5%1.1%Yield1.1%$1.00TAssets$875B0–0levelEnd-of-day Nov 13, 2026
SCHD vs VIGYTDSchwabSCHDSA+34.9%vsBVVIGVanguard+16.0%Jan 1Nov 13+34.9%+16.0%+34.9%Year to date+16.0%2.9%Yield1.4%$124BAssets$109B2–0SCHD winsEnd-of-day Nov 13, 2026
Overlap: PPH, SPYM, IVVToday99.9%most shared, SPYM and IVVPPHSPYMIVVPPH—5.0%5.0%SPYM5.0%—99.9%IVV5.0%99.9%—End-of-day Nov 13, 2026 · share held in common · outlined: the pair in versus
Income After Fees on $10,0001Y$138most kept, PPHPPH$174 − $36 = $138IVV$111 − $3 = $108SPYM$103 − $2 = $101KeptFeeEnd-of-day Nov 13, 2026 · yield in dollars minus the fee